Immune evasion is a defining feature of KRAS-driven cancer, whereas KRAS produces immunosuppressive effects in tumour tissue by promoting macrophage M2 polarisation (suppressing-inflammatory phenotype), thereby creating a more hospitable TME ecological niche for cell proliferation and metastasis (Ischenko et al., 2021). Here, KRAS is linked to neoplasm.